-
Aedes aegypti Xenobiotic Transport After Alizarin Exposure
2026-08-30
Kennel and Rouhier examined how injected xenobiotics affect excretion, mortality, and putative organic cation transporter expression in female Aedes aegypti. The study’s central contribution is the finding that molecular structure strongly influenced excreted material and physiological outcome, whereas transporter mRNA profiles changed only modestly, highlighting xenobiotic transport as an undercharacterized target for vector-control research.
-
GSK2606414: A Causal Map of ER Stress Signaling
2026-08-29
GSK2606414 is a selective PERK inhibitor for dissecting translational control, ER stress research, and Nrf2-linked redox responses. This article presents a time-resolved strategy for separating PERK-dependent signaling from infection-associated mechanisms that alter Nrf2 stability.
-
IL-12 mRNA and the Extrahepatic Frontier
2026-08-28
A translational strategy for using Mouse Interleukin-12 mRNA in advanced immunotherapy research, connecting transcript chemistry with extrahepatic delivery, immune pharmacology, and evidence-driven development decisions.
-
Phosphotungstic Acid Negative Stain Solution Guide
2026-08-28
Turn fragile viruses, glycoproteins, and macromolecular assemblies into high-contrast electron microscopy targets with a ready-to-use negative stain workflow. This guide connects practical grid preparation and troubleshooting with new coronavirus glycan research, while clarifying what imaging can—and cannot—prove.
-
Central Opioid Circuits in Mechanical Hypersensitivity
2026-08-27
Yin et al. identify a lateral parabrachial-to-hypothalamic-to-spinal opioid pathway that controls morphine-induced mechanical hypersensitivity and analgesic tolerance in mice. The study separates mechanical pain adaptation from thermal opioid responses and shows that circuit-level intervention can rescue these paradoxical effects, offering a useful framework for opioid receptor signaling research and chronic pain research.
-
Intestinal Stretch, Obesity, and Weight Loss
2026-08-27
The reference study shows that intestinal stretch is an acute regulator of food intake and glucose tolerance that operates independently of classical GLP-1 signaling. It further demonstrates that obesity weakens this gut–brain response, whereas dietary or surgical weight loss restores it, refining how researchers interpret gastrointestinal mechanosensation in metabolic disease.
-
Dynasore: Practical Dynamin Inhibition Guide
2026-08-26
Dynasore is a cell-permeable dynamin GTPase inhibitor for experimentally perturbing dynamin-dependent endocytosis, vesicle trafficking, and related cellular readouts. This guide explains how to prepare and control Dynasore assays, while clarifying that it should not be treated as a pathway-exclusive probe, therapeutic, or substitute for orthogonal validation.
-
Disulfiram: Proteasome and Pyroptosis Research Guide
2026-08-26
Disulfiram is a dopamine β-hydroxylase inhibitor and aldehyde dehydrogenase inhibitor with established alcohol-dependence use and expanding preclinical roles in proteasome, cancer, and inflammasome research. Copper-associated proteasome inhibition and GSDMD-directed pyroptosis modulation are distinct experimental mechanisms that require separate controls.
-
In Vitro Embryonic Dormancy Through mTOR Inhibition
2026-08-25
The Nature Protocols paper converts pharmacologically induced mTOR inhibition into a detailed, reversible in vitro workflow for placing mouse blastocysts, human blastoids, and pluripotent stem cells into a diapause-like state. Its main practical contribution is a noninvasive and scalable framework for studying dormancy, reactivation, and developmental competence across mammalian models.
-
Dantrolene sodium salt: RyR Workflows
2026-08-25
Dantrolene sodium salt provides a reversible way to interrogate ryanodine receptor-driven calcium release in cardiomyocyte, pancreatitis, and disease-modeling workflows. This guide pairs calcium imaging and viability controls with an exploratory CRISPR repair-outcome assay, clearly separating established RyR biology from emerging cross-domain questions.
-
WEHI-539: A Selective BCL-XL Inhibitor Workflow
2026-08-24
WEHI-539 enables selective interrogation of BCL-XL-dependent survival, mitochondrial apoptosis, and resistance states without the interpretive ambiguity of broad BCL-2-family perturbation. This workflow connects formulation control, mechanistic apoptosis readouts, cancer stem cell sensitization, and MCL-1-focused combination studies.
-
GSK2606414 PERK Inhibitor: Workflow Guide
2026-08-24
GSK2606414 provides a precise way to test whether PERK signaling drives ER-stress responses, lipid injury, cell death, or tumor adaptation. This workflow guide translates a TMAO–NAFLD study into practical dose-finding, pathway-validation, troubleshooting, and cross-model assay strategies.
-
Paroxetine Mesylate Research Workflows
2026-08-23
Paroxetine Mesylate supports more than conventional serotonergic studies: it can connect SERT pharmacology with kinase-focused colorectal cancer assays. This guide converts that multi-target profile into practical workflows, controls, and troubleshooting decisions for translational researchers.
-
DAMGO and the Circuit Logic of Opioid Pain
2026-08-22
DAMGO is more than a selective µ-opioid receptor agonist: it is a precision probe for connecting receptor activation with tissue responses, brain-to-spinal circuits, mechanical hypersensitivity, and translational risk in chronic pain research.
-
PYR-41: Designing Better Ubiquitination Assays
2026-08-21
PYR-41, an inhibitor of Ubiquitin-Activating Enzyme E1, can reveal how ubiquitination controls inflammatory signaling. This article translates recent ESCC B-cell findings into a practical assay strategy while defining the compound’s selectivity and interpretation limits.